Drug Type miRNA |
Synonyms MYR 103 |
Target |
Mechanism PLP1 inhibitors(proteolipid protein 1 inhibitors), RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Myrtelle, Inc.Startup |
Active Organization Myrtelle, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |